Preparation of Immunoglobulins and Proteolytic Fragments.
Ascites fluid from the 2.4G2 hybridoma was adjusted to 45% saturation with (NH4)2SO4. The precipitate collected by centrifugation was dissolved in PBS and subjected to Sephadex G-200 chromatography (Pharmacia Fine Chemicals, Div. of Pharmacia Inc.). The IgG peak from the Sephadex G-200 column was dialyzed against 0.025 M Tris-HC1, pH 8 and 100 mg of protein applied to a 2 X 5-cm column of DE-52 (Whatman, Inc., Clifton, N. J.). The column was eluted with a 500 ml 0-0.5 M gradient of NaCI dissolved in 0.025 M Tris-HCl, pH 8. The 2.4G2 IgG eluted at 0.1 M NaCI. To prepare the Fab fragment, the purified IgG was digested with a 1:100 wt/wt ratio of papain for 16 h at 37°C as described by Porter (25) . The digest was purified on a DE-52 column as described above. The Fab fragment eluted at 0.09 M NaCI.
The mouse IgG2a myeloma protein LPC-1 and rabbit anti-DNP IgG were prepared as described previously (11, 12) .
CD2F1 mouse anti-DNP IgG was prepared from ascites fluid from mice immunized repeatedly with DNP-keyhole limpet hemocyanin as described by Tung et al. (26) . The anti-DNP IgG from the ascites fluid was isolated as described (12) . To isolate IgGx, which does not bind to protein A (27) , anti-DNP IgG (4.5 mg) was passed sequentially over two 0. Iodinations. Proteins (50 ~g each) were iodinated with 500 pCi of 12SINa (Amersham Corp., Arlington Heights, I11.) using chloramine T at a molar chloramine T:IgG ratio of 10:1 as described (11, 28) . Incorporation of 12sI into protein was >50%.
Immunofluorescence. Viable adherent cells were seeded on glass coverslips. Nonadherent cells in medium without serum were centrifuged (200 g, 10 min) onto 12-mm diameter acid-washed coverslips which had previously been incubated for 30 min in 50 pg/ml poly-L-lysine (34,000 mol wt, Sigma Chemical Co., St. Louis, Mo.), dissolved in PBS, and then rinsed in water. After the cells had been centrifuged onto the slips, they were transferred to medium with serum. The coverslips were then incubated with 2.4G2 IgG (30/zg/ml) or a 1:200 dilution of ascites in PBS containing 1 mg/ml of crystallized bovine albumin (PBS-BSA) for 30 min at 4°C. After gentle rinsing, the cells were stained for 30 min at 4°C with a 1:20 dilution ofa tetramethyl rhodamine isothiocyanate (TRITC)-rabbit anti-rat IgG F(ab')2 reagent (N. L. Cappell Laboratories, Inc., Cochranville, Pa.), rinsed, and fixed in 10% buffered neutral formalin. Cells were screened for surface IgM by staining with a fluorescein isothiocyanate-coupled rabbit anti-/~ reagent (29) . Specimens were viewed with a X 63 oil immersion lens on a Zeiss microscope with epifluorescence optics (Carl Zeiss, Inc., N. Y.).
Immunoelectrophoresis and Ac!ylamide Gel Electrophoresis. Immunoelectrophoresis was performed in 2% agar, 0.05 M Na barbital, pH 8.2, and the slide developed with a rabbit anti-rat IgG (N. L. Cappell Laboratories, Inc.). Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis was performed as described by Neville (30) using 1-mm thick slab gels with a 4-1 I% gradient of acrylamide. Sample buffer was 50 mM Na2COa pH 8.4, 2% SDS, 50 mM dithiothreitol, 12% wt/vol sucrose.
Binding Studies. Washed cells (5-10 X 105) were incubated in suspension with 125I-2.4G2
IgG in PBS-BSA at 4°C for 1 h. After dilution with 3 ml cold PBS-BSA, they were centrifuged at 500 g for 5 rain, and the supernate was removed. The pellet was washed with 3 ml of PBS-BSA, recentrifuged, and the tubes assayed for radioactivity after removal of the supernate. The washing removed 99.4% of input radioactivity from both empty tubes and negative cell lines. Experiments were usually carried out using a constant trace amount of 125I-2.4G2 IgG with variable amounts of nonradioactive 2.4G2 IgG so that the specific activity was between 104 and 106 cpm//~g. (Table I) ; lane F, 125I-Fab adsorbed to J774 cells in first cycle (Table I) . Autoradiograms were exposed on Dupont Cronex x-ray film for I d. Standards used to determine molecular weights were soybean trypsin inhibitor (21,500 daltons), ovalbumin (43,000 daltons), and BSA (68,000 daltons).
Results

Characterization of the
spleen cells, which yielded >1,000 hybridoma clones, only one hybridoma-making antibody of the desired specificity was isolated, 2.4G2. O f the >100 clones with secreted anti-macrophage antibodies, determined by immunofluorescence, none had any effect on EIgG2b rosette formation.
The purified 2.4G2 hybridoma antibody had one type of heavy chain, of apparent mol wt 52,000, and two different types of light chains, one of which derived from the P3U1 myeloma, and one which came from the rat spleen B cell (Fig. 1 A) . After digestion with papain there was no visible intact heavy chain, and two heavy chain fragments, of apparent mol wt 30,000 and 26,000 were seen (Fig. 1 B) . J u d g e d by Coomassie Blue staining, the relative abundance of these two new fragments was approximately the same as the relative abundance of the two light chains, which were not altered in electrophoretic mobility after papain digestion. This result suggests that the type of light chain associated with the heavy chain determined the extent of papain digestion of the latter.
To ascertain which type of light chain in the hybridoma IgG was of rat spleen cell origin, the purified Fab fragments were iodinated, and sequential adsorptions were carried out with either J774 cells or a non-FcR-bearing lymphoid line, L5178Y. The results (Table 1) show that >50% of the 125I incorporated into the Fab fragments was bound to J774 cells. The amount bound in the third adsorption was only 20% of that bound in the first. Little radioactivity (0.5% of the initial 125I) was adsorbed by L5178Y cells. The t25I-Fab adsorbed to the first aliquot ofJ774 cells and the supernate from the final adsorption were reduced and analyzed by SDS polyacrylamide gel electrophoresis. The autoradiogram (Fig. 1 E) shows clearly that the more rapidly migrating H-chain fragment was adsorbed from the azsI-Fab (Fig. 1 D) . Only the Fab fragments composed of the rapidly migrating heavy chain fragment--light chain pair bound to the J774 cells ( Fig. 1 F) . Assuming that the homologous rat light chain-rat heavy chain combination results in the formation of the antibody binding site, this experiment defined the rat light chain as the more rapidly migrating peptide.
The intact hybridoma antibody was tested by Ouchterlony diffusion against goat anti-IgM, IgE, IgA, and IgG antisera, generously supplied by Doctors Teruko and Kimishige Ishizaka (Johns Hopkins School of Medicine, Baltimore, Md.), and formed a precipitin line only with anti-IgG (not shown). The 2.4G2 IgG does not bind to protein A (not shown). Of the four rat IgG subclasses, Medgyesi et al. (31) have shown that only rat IgG2a and IgG2b fail to bind to protein A. However, the assignment of the hybridoma IgG to either of these subclasses must be provisional, because both are reported to migrate rapidly towards the cathode (32), and 2.4G2 IgG migrates very slowly relative to the bulk of rat IgG (Fig. 2) .
Inhibition ofMacrophage FcR. Preincubation ofJ774 cells with different dilutions of 2.4G2 ascites fluid followed by rinsing to remove unbound hybridoma antibody resulted in striking inhibition of EIgG2b binding to Fc receptors (Figs. 3b, c). This inhibition was observed even at a 1:16,000 dilution of the original ascites (Fig. 3 d) .
To test the possibility that the inhibition of the Fc receptors was not a result of the hybridoma binding to the cell surface via the antibody combining site but a result of the blockade of Fc receptors by the Fc domain of the hybridoma antibody, the Fab fragment of 2.4G2 IgG was prepared.
The Fab fragment of 2.4G2 IgG inhibited the binding of EIgG2b to macrophages ( Fig. 4b ) relative to the control (Fig. 4a) , although not to the same extent as the intact hybridoma antibody (Fig. 4c) . The monovalent Fab fragment probably has a lower affinity for the antigenic site than the bivalent 2.4G2 IgG, and thus does not inhibit EIgG2b rosette formation as efficiently. Similar results were obtained using E derivatized with TNP groups which were then coated with mouse anti-DNP IgG1 (ETNP IgG1). These erythrocytes bound avidly to J774 cells (Fig. 4 d) but did not bind to J774 cells preincubated with either the Fab fragment (Fig. 4e) or the intact hybridoma antibody (Fig. 4 f) . Thus, the inhibition of rosetting of EIgG2b and ETNP IgG1 to macrophages by the monoclonal antibody was a result of the antigenic Fro. 2. Immunoelectrophoresis of 2.4G2 IgG and rat serum. The top well was loaded with 15 #l of 1.15 mg/ml 2.4G2 IgG, the bottom well with 15 p.l normal rat serum. After electrophoresis, the center well was filled with rabbit anti-rat IgG, and developed overnight.
binding site of the antibody, and not to immune blockade of Fc receptors by the Fc domain.
A different pattern of Fc receptor inhibition by the hybridoma antibody and Fab fragment was observed when EIgG2a binding to macrophages was tested. Rosette formation with EIgG2a was blocked by preincubation with 2.4G2 IgG (Fig. 4j) but was unaffected by preincubation with the Fab fragment (Figs. 4 g, h) . We also tested the binding of monomeric l~sI-IgG2a (11) to J774 cells after preincubation of the J774 cells with 2.4G2 IgG or the Fab fragment. There was no inhibition by the F(ab) fragment, and the intact hybridoma antibody inhibited binding of monomeric IgG2a totally (not shown). Thus, the inhibition of IgG2a and EIgG2a binding by the hybridoma antibody was a result of Fc domain blockade of the FcRI site. The antigenic site to which 2.4G2 IgG binds is unrelated to the IgG2a-specific Fc receptor site. It appears likely that mouse IgG2a, whether aggregated or monomeric, binds to a receptor distinct from that which binds aggregated IgG2b, as discussed by Diamond et al. (14) .
Binding of 2. 4G2 IgG to Macrophage FcR Variants.
A set of variants of the J774 mouse macrophage cell line had been previously isolated which bound only 1-3 E coated with IgG2b compared to 25 or more for the J774 parent. The variants lacked the trypsin-resistant FeR for IgG2b aggregates (FcRII), but not FcRI which binds mouse IgG2a (17) . The binding of the 2.4G2 IgG to these variants and the parent cell line was examined by immunofluorescence using a T R I T C -r a b b i t anti-rat IgG F(ab')2 reagent to stain viable cells first incubated with 2.4G2 IgG (Fig. 5) . The variants showed a dramatic lack of immunofluorescence compared to the parent, indicating the absence of the antigenic determinant recognized by 2.4G2 IgG.
These experiments were repeated using a quantitative assay of the binding of a2sI-2.4G2 IgG to the same cell lines. A preliminary experiment established that there was no detectable dissociation of bound 12~I-2.4G2 IgG from the surface ofJ774 cells over a 3-h period (not shown). The results of the quantitative binding experiment (Fig. 6) confirmed the immunofluorescence data. The parent J774 cells bound 0.15 /~g of 2.4G2 IgG per 106 cells, ~600,000 IgG molecules per macrophage. The binding to J774 cells of 12SI-Fab fragment was similar to the intact 2.4G2 IgG except that slightly less of the Fab fragment bound at saturation. Trypsinization of the J774 cells had no effect on subsequent binding of 125I-2.4G2 IgG.
Because the variants were all isolated from independent mutagenizations ofJ774 
Binding of 2.4G2 IgG and Inhibition of FcR on Macrophages and Other Cells.
A n a d v a n t a g e of m o n o c l o n a l sera over c o n v e n t i o n a l antisera is that they c a n be used to define a u n i q u e antigenic d e t e r m i n a n t on a variety of cell types without the necessity of adsorption to remove u n w a n t e d specificities. First a series of cell populations was screened for b i n d i n g of 2.4G2 IgG by immunofluorescence. Binding was detected using a T R I T C -r a b b i t anti-rat IgG F(ab')2 as the second reagent. In this assay To obtain more quantitative data, the binding of 125I-2.4G2 to a series of mouse lymphoid lines was studied (Fig. 7) . Cells binding 2.4G2 IgG were the P388 lymphoma, PU5.1, and WEHI-231. Cells which did not bind 2.4G2 IgG (giving a background of binding identical to serum-coated empty tubes) were L5178Y, EL-4, TLX-9, thymocytes, and splenic dendritic ceils isolated by the procedure of Steinman et al. (33) . In addition to screening for the binding of 2.4G2 IgG, the ability of the monoclonal antibody to inhibit rosetting was also examined. These experiments were done using opsonized ox erythrocytes (EoxIgG), which can be coated with a higher density of IgG than sheep erythrocytes without agglutinating (34) and thus are a more sensitive indicator than EIgG for FcR. Table II shows that the cells which bound 2.4G2 IgG formed rosettes (J774, P388, PU5.1, and WEHI-231) and that preincubation with the monoclonal antibody blocked the binding of EoxIgG. The extent of rosetting was roughly proportioned to the amount of 2.4G2 IgG bound. Rosette formation by WEHI-231, which bound only 30,000 molecules of the hybridoma IgG per cell, could not be demonstrated using EIgG, and was weak even with EoxIgG. The extent of rosetting by EL-4, L5178Y, TLX-9, and thymocytes was very low and, with the exception of thymocytes, where ~1% of the cells formed rosettes with >I1 E, no heavily rosetted cells were found.
To rule out the possibility that antigen recognized by 2.4G2 IgG was present only Protocol for rosette formation was as detailed in Table II. on cells of the H-2d haplotype (because the J774 cells used for immunization of the rat are of BALB/c origin) peritoneal cells and spleen cells from a number of different inbred mouse strains were screened. The results (Table III) show that ~40% of spleen cells from all strains tested formed EIgG rosettes, which is in agreement with previous results (35) (36) . The percentage of EoxIgG rosetting cells in the resident peritoneal cell population was more variable, but preincubation with 2.4G2 IgG inhibited formation of EoxIgG rosettes in all cases in both spleen cells and resident peritoneal cells. I attempted to screen for mouse neutrophil Fc receptor inhibition but could not obtain satisfactory rosetting in controls using cells from mouse peripheral blood, or from mouse peritoneal cavity 17 h after injection of 1 ml of thioglycollate medium.
Fc Receptors on Cells of Other Species.
Peritoneal cells from rabbit, guinea pig, and rat, as well as human peripheral blood mononuclear cells and granulocytes, were tested to see if the 2.4G2 IgG inhibited binding of EIgG. Preincubation with the hybridoma antibody did not block EIgG rosetting on any of these cells. There was some binding over background of 12~I-2.4G2 IgG to guinea pig peritoneal cells, but this appeared to be Fc domain-mediated because there was no binding of the 125I-Fab fragment. Thus, the antigenic site recognized by the hybridoma antibody is specific for a mouse determinant.
Discussion
The striking ability of macrophages and some lymphocytes to bind erythrocytes coated with IgG is a result of the presence of Fc receptors on the plasma membranes of these cells. These receptors confer specificity in the phagocytosis of antibody-coated particles by macrophages (37) , and in the destruction of target cells by lymphoid K cells and macrophages (38) in the presence of an appropriate anti-target cell antibody. The function of the FcR on B lymphocytes is not clear, but the interaction of complexes with FcR may be involved in regulation of the immune response (1-3) .
The development of the technique for making monoclonal antibodies (16) has opened exciting possibilities for dissection of immunogenic cell surface components, and I felt this approach might be fruitful for studying FcR. The search for a monoclonal anti-FoR antibody was based on the assumption that such an IgG would block the binding of EIgG2b which were used in the screening assay. There have been reports of inhibition of Fc receptors on B cells by IgG and F(ab')2 fragments directed against a variety of surface markers including Ia, H-2D, H-2K, Ly4.2, and mouse immunoglobulin (see Halloran and Schirrmacher [39] for review). Inhibition of mouse macrophage FcR by Fab or F(ab')2 fragments of anti-mouse macrophage IgG has also been reported (40) . Because it is unlikely that all of these allergeneic and xenogeneic sera are directed against FcR, it appears more likely that inhibition is a result of steric blockage of the receptors or to perturbation of the membrane in an as yet undefined manner. A series of monoclonal antibodies I have isolated, which are directed against various macrophage surface determinants, have no inhibitory effect on either FcR or the C' receptor, suggesting that the polyvalent character of the allogeneic and xenogeneic sera mentioned above may be an important factor in their ability to inhibit FcR.
The evidence that the monoclonal IgG secreted by the 2.4G2 hybridoma has an anti-FcR antigenic specificity rests in part on the binding of the antibody to different cell types. A series of independently isolated variants of the J774 macrophage-like cell line which were unable to bind EIgG2b (17) bound 5% as much 2.4G2 IgG as the parent clone bound. Also, all cells which failed to form EoxIgG rosettes (L-cells, TLX-9, P3U1, L5178Y, EL-4, and thymocytes) failed to bind 125I-2.4G2 in a quantitative and sensitive binding assay. Conversely, cell lines which did form EoxIgG rosettes (P338, P388D1, J774, PU5.1, and WEHI-231) bound 125I-2.4G2 IgG. Mixed cell populations from mouse peritoneal cavity or spleen, after preincubation with 2.4G2 IgG, did not form rosettes with EoxIgG. The inhibition of FcR on a variety of different cell types, from different H-2 backgrounds, and the absence of the antigen-recognized by the hybridoma antibody on FcRII negative mutants of a macrophage cell line both suggest strongly that the 2.4G2 IgG recognizes an antigenic determinant on FcRII.
The inhibition of binding of EIgG2b and EIgG 1, but not EIgG2a by preincubation of macrophages with the Fab fragment of the hybridoma antibody demonstrates that the two macrophage Fc receptors are different antigenically. The result is consistent with the report by Diamond et al. (14) that binding of EIgG2a and EIgG2b is inhibited only by the homologous subclass of aggregated mouse IgG, but is not in agreement with Heusser et al. (13) , who concluded that the trypsin resistant receptor bound aggregated antibody of all mouse subclasses. The inhibition of IgG2a and EIgG2a binding by preincubation of macrophages with the intact hybridoma antibody is apparently a result of immune blockade of the FcRI site by the hybridoma IgG Fc domain.
An important result of these experiments is the definition of a common determinant on macrophages and some lymphoid cells. The relative ease with which rabbit IgG-coated E (which bind via both FcRI and FcRII [14, 17] ) form rosettes on macrophages compared to lymphoid cells is probably a result of the presence of FcRI on macrophages and possibly to a higher density of FcRII sites. Lymphoid cells which bind monomeric IgG2a poorly (13) In the present study, thymocytes did not form EoxIgG rosettes, nor did they bind 2.4G2 IgG. However, there is no doubt that there are Thy-1 positive lymphoid lines which bear FoR (13, 45, 50) , and it is possible that a subpopulation ofT cells in the spleen have FcR which bear the 2.4G2 antigenic determinant. Cell fractionation studies are in progress to resolve this question.
Studies are planned to isolate and characterize the antigen recognized by the 2.4G2 IgG and to reconstitute, if possible, the FcRII molecule in lipid micelles. The antibody will also aid in understanding the role of FcR in the biological function of cells which bear the determinant.
Summary
To investigate the antigenic relationship between the macrophage and lymphocyte Fc receptors (FcR), a monoclonal antibody capable of blocking mouse macrophage Fc receptors was selected. Hybrids were formed by fusing the P3U 1 mouse myeloma and spleen cells from a rat immunized with the mouse macrophage-like cell lines J774 and P388D1. The Fab fragment of the monoclonal IgG secreted by clone 2.4G2, inhibited the trypsin-resistant Fc receptor II (FcRII), which i s specific for immune aggregates of mouse IgG1 and IgG2b, but had no inhibitory effect on the trypsinsensitive Fc receptor I (FcRI), which binds monomeric IgG2a and erythrocytes coated with IgG2a. Thus, the monoclonal 2.4G2 IgG appeared to be specific for macrophage FcRII.
Further evidence that the 2.4G2 IgG was directed against FcRII came from binding studies of the monoclonal antibody to J774 cells and a series of independently isolated variants which do not express FcRII. These variants ofJ774 bound 5% as much of the monoclonal antibody as the parent line, which bound 600,000 molecules of 2. Received for publication 17 May 1979. 
